Abstract: In one aspect, a method for emotion mapping where computing device can generate an emotional dyad, wherein the emotional dyad comprises two different emotion states. The emotion dyads can be displayed with a degree of separation for receiving an input on a scale from an individual. The computing device can receive an input of a first endpoint anchor and a second input anchor on the dyad scale. Next, the computing device receives input of an emotion anchor within the degree of separation. The computing device can subsequently calculate the length of separation from the first endpoint anchor and the second endpoint anchor, the length of separation being a neutral region, and lengths outside of the neutral region being emotion regions. The computing device determines a user's assessment by averaging the neutral region, the endpoint anchors, and an emotion anchor in one or more cycles.

Abstract: The present subject matter provides processes and kits for identifying the presence of waste water or human-derived pathogens, particularly those associated with the presence of human fecal matter, in surface or subsurface water sources.

Abstract: Methods for determining the toxicity of fresh-water and marine sediments and sediment pore water containing indigenous or introduced toxicants from each as a one-time analysis and/or for analysis over a period of time are provided. The present disclosure further provides kits assembled for the afore-mentioned determination. The methods and kits can be used for analyzing sediment and pore water samples from, among other locations, all environments where species having a dormant life stage may exist including, for example, natural zooplankton.

Abstract: A portable isometric neck assessment system and method is provided, comprising an isometric neck strength device comprising a measurement component, an anchor line for connecting the isometric neck strength device to a stationary object, and a tension line for connecting the isometric neck strength device to a head strap. Based on an isometric neck movement of a user, the system can generate and record a strength measurement associated with the isometric neck movement of the user, and further wirelessly transmit the strength measurement to an application or storage system.

Abstract: The present subject matter provides processes and kits for identifying the presence of waste water or human-derived pathogens, particularly those associated with the presence of human fecal matter, in surface or subsurface water sources.

Abstract: The present subject matter provides processes and kits for identifying the presence of waste water or human-derived pathogens, particularly those associated with the presence of human fecal matter, in surface or subsurface water sources.

Abstract: The present invention provides methods for determining the toxicity of fresh-water and marine sediments and sediment pore water containing indigenous or introduced toxicants from each as a one-time analysis and/or for analysis over a period of time. The present invention further provides kits assembled for the afore-mentioned determination. The methods and kits of the present invention can be used for analyzing sediment and pore water samples from, among other locations, all environments where species having a dormant life stage may exist including, for example, natural zooplankton.

Abstract: The present disclosure provides methods for determining the toxicity of fresh-water and marine sediments and sediment pore water containing indigenous or introduced toxicants from each as a one-time analysis and/or for analysis over a period of time. The present disclosure further provides kits assembled for the afore-mentioned determination. The methods and kits of the present disclosure can be used for analyzing sediment and pore water samples from, among other locations, all environments where species having a dormant life stage may exist including, for example, natural zooplankton.

Abstract: The present subject matter provides processes and kits for identifying the presence of waste water or human-derived pathogens, particularly those associated with the presence of human fecal matter, in surface or subsurface water sources.

Abstract: The present invention provides methods for determining the toxicity of fresh-water and marine sediments and sediment pore water containing indigenous or introduced toxicants from each as a one-time analysis and/or for analysis over a period of time. The present invention further provides kits assembled for the afore-mentioned determination. The methods and kits of the present invention can be used for analyzing sediment and pore water samples from, among other locations, all environments where species having a dormant life stage may exist including, for example, natural zooplankton.

Abstract: A set of training vectors may be identified. Each training vector may be mapped to either a male gender or a female gender, and each training vector may represent facial landmarks derived from a respective facial image. An input vector of facial landmarks may also be identified. The facial landmarks of the input vector may be derived from a particular facial image. A feature vector may containing a subset of the facial landmarks may be selected from the input vector. A weighted comparison may be performed between the feature vector and each of the training vectors. Based on a result of the weighted comparison, the particular facial image may be classified as either the male gender or the female gender.

Abstract: A facial image may be annotated with the plurality of facial landmarks. These facial landmarks may be points or regions of the face that are indicative, either alone or in combination with other facial landmarks, of at least one demographic characteristic. Demographic characteristics include, for example, age, race, and/or gender. Based on the demographic characteristic being analyzed, one or more of these facial landmarks may be selected and arranged into an input vector. Then, the input vector may be compared to one or more of the training vectors. An outcome of this comparison may involve in the given facial image being classified into a category germane to the analyzed demographic characteristic (e.g., an age range or age, a racial category, and/or a gender).

Abstract: Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.

Abstract: A set of training vectors may be identified. Each training vector may be mapped to either a male gender or a female gender, and each training vector may represent facial landmarks derived from a respective facial image. An input vector of facial landmarks may also be identified. The facial landmarks of the input vector may be derived from a particular facial image. A feature vector may containing a subset of the facial landmarks may be selected from the input vector. A weighted comparison may be performed between the feature vector and each of the training vectors. Based on a result of the weighted comparison, the particular facial image may be classified as either the male gender or the female gender.

Abstract: A facial image may be annotated with the plurality of facial landmarks. These facial landmarks may be points or regions of the face that are indicative, either alone or in combination with other facial landmarks, of at least one demographic characteristic. Demographic characteristics include, for example, age, race, and/or gender. Based on the demographic characteristic being analyzed, one or more of these facial landmarks may be selected and arranged into an input vector. Then, the input vector may be compared to one or more of the training vectors. An outcome of this comparison may involve in the given facial image being classified into a category germane to the analyzed demographic characteristic (e.g., an age range or age, a racial category, and/or a gender).

Abstract: A facial image may be annotated with the plurality of facial landmarks. These facial landmarks may be points or regions of the face that are indicative, either alone or in combination with other facial landmarks, of at least one demographic characteristic. Demographic characteristics include, for example, age, race, and/or gender. Based on the demographic characteristic being analyzed, one or more of these facial landmarks may be selected and arranged into an input vector. Then, the input vector may be compared to one or more of the training vectors. An outcome of this comparison may involve in the given facial image being classified into a category germane to the analyzed demographic characteristic (e.g., an age range or age, a racial category, and/or a gender).

Abstract: Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.

Abstract: Disclosed are compounds that are conjugates of ladder frame polyether compounds and biologically active compounds or research compounds, pharmaceutical formulations comprising the conjugates, and methods of transporting the conjugates across biological membranes.

Abstract: Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of regulating mucus clearance in a cell, and methods of treating decreased mucus clearance or mucociliary dysfunction.

Abstract: Disclosed are methods of treating neurodegenerative diseases or disorders in a subject in need of such treatment. The methods comprise administering to a subject in need of such treatment a therapeutically effective amount of brevetoxin or brevetoxin derivatives. Included in the diseases and disorders are Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Multiple sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease) and other Motor Neuron Diseases, Prion Diseases, Frontotemporal Dementia (FTD), and CNS dysfunctions such as schizophrenia, depression, and epilepsy. Also included are neurodegenerations resulting from stroke, heart attack, head and spinal cord trauma, traumatic brain injury, bleeding in the brain and other injuries to the central nervous system (CNS).